Blog

Spring Gala Celebrating Connections At the Gala on April 27, Alzheimer’s New Jersey was pleased to recognize two leaders in the New Jersey fight against Alzheimer’s disease. Russell Rothman and Heather Rae Stafford [View More]

On Friday, January 6, the US Food and Drug Administration gave accelerated approval to Leqembi™ (lecanemab – irmb), a drug developed by Eisai in partnership with Biogen, for the treatment of Alzheimer’s disease. The drug [View More]

I’ve been a fan of Bruce Springsteen’s music for as long as I can remember. His “stories” have spoken to me in different ways during different periods of my life. Perhaps, that comes from [View More]

Recently released data from Eisai’s Phase 3 clinical trial of lecanemab shows that the drug slowed the rate of cognitive decline by 27% as compared to the placebo group in an 18-month study of participants [View More]

Watch Alzheimer's New Jersey CEO Ken Zaentz discuss the impact of Alzheimer's on the New Jersey Morning Show

This weekend as we celebrate Father’s Day, I want to share a message with men who find themselves in the role of caregiver – particularly those in The Silent Generation (1925-1945) and The Baby Boomer [View More]